| Literature DB >> 24600402 |
Jose Gutierrez1, Gorazd Rosoklija2, Jacinta Murray3, Christina Chon3, Mitchell S V Elkind4, James Goldman5, Lawrence S Honig1, Andrew J Dwork6, Susan Morgello3, Randolph S Marshall1.
Abstract
Mechanisms underlying brain arterial remodeling are uncertain. We tested the hypothesis that arterial size and location are important determinants of arterial characteristics. We collected large and penetrating brain arteries from cadavers with and without HIV. Morphometric characterization was obtained from digital images using color-based thresholding. The association of arterial size and location with lumen diameter, media and adventitia area, media proportion, a wall thickness, wall-to-lumen ratio and stenosis was obtained with multilevel mixed models and a P value ≤ 0.05 was considered significant. We included 336 brains, in which 2279 large arteries and 1488 penetrating arteries were identified. We found that arterial size was significantly associated with all arterial characteristics studied of large and penetrating arteries with exception of arterial stenosis in large arteries. After adjusting for size, an independent association was found between lumen diameters, media and adventitia thickness with artery locations. Arterial stenosis was also associated with artery location in both large and penetrating arteries. In summary, significant effects of size and/or location were found in arterial characteristics typically used to define arterial remodeling. Brain arterial remodeling characteristics differ across arterial sizes and location, and these differences should be controlled for in future studies of brain arterial remodeling.Entities:
Keywords: HIV; arterial remodeling; brain arteries; cardiovascular disease; media thickness; stenosis
Year: 2014 PMID: 24600402 PMCID: PMC3928551 DOI: 10.3389/fphys.2014.00056
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Examples of arterial identification. (A) Circle of Willis, identification, and section of arterial segments. (B) Identification of penetrating arteries neighboring the parent large artery. D, distal; P, proximal.
Characteristics of the tissue repositories from which the brain arteries were obtained.
| Institution | Mount Sinai School of Medicine | New York Psychiatric Institute | Columbia University Medical Center | University of Miami |
| Type of study | Cohort, living subjects followed prospectively until they die | Cross-sectional, retrospective data collection | Cross-sectional, retrospective data collection | Cross-sectional, retrospective data collection |
| Population studied | Individuals with HIV and HIV negative controls | Individuals with psychiatric diseases and negative controls | Individuals with neurodegenerative disease including AD | Individuals with neurological and psychiatric diseases and negative controls |
| Number of donors for this study | ||||
| Origin of the studied sample | Predominantly from inner city neighborhoods in Manhattan (East and Central Harlem), Bronx, and Brooklyn, NY | 78% obtained from Macedonia, 22% obtained from a hospital-based autopsy service in NY | Metropolotan area of New York, NY | Metropolitan area, Miami, FL |
| Vascular risk factor definition | Chart review, self-report during professional interview, or inferred based on medication list | Chart review of subjects who die institutionalized, and/or psychological autopsy based on family interviews | Chart review, self-report by interview of prospective donors | Chart review, self-report by interview of prospective donors |
| Laboratory results | Obtained at scheduled visits during follow up | Retrieved from chart reviews when available | Retrieved from chart reviews when available | Retrieved from chart reviews when available |
| Website link | MHBB | M/NYPSI Brain Collection | NYBB | BEB |
| Age (mean ± | 50.0 ± 10.6 | 50.3 ± 11.9 | 81.9 ± 9.8 | 55.7 ± 23.1 |
| Male sex (%) | 70 | 71 | 44 | 56 |
| Ethnicity (%) | ||||
| NH-whites | 24 | 88 | 88 | 67 |
| NH-Blacks | 41 | 7 | 0 | 33 |
| Hispanics | 35 | 5 | 12 | 0 |
Abbreviations: AD, Alzheimer Dementia; NH, non-Hispanic; SD, standard deviation; NYSPI, New York Psychiatric Brain Institute.
Arterial characteristics by arterial segment.
| Proximal ICA (supraclinoid) ( | 3.9±0.9 | 2.9±0.8 | 200.8±68.9 | 40.2±9.7 | 159.8±60.2 | 529.8±232.1 | 19.9±14.9 | 6.2±2.5 |
| Distal ICA (supraclinoid) ( | 3.8±0.8 | 2.9±0.7 | 189.8±52.8 | 43.4±8.9 | 140.6±36.5 | 451.5±141.2 | 15.1±10.4 | 7.0±2.6 |
| Proximal M1 MCA ( | 3.1±0.7 | 2.3±0.6 | 149.5±42.7 | 41.1±9.1 | 134.4±33.7 | 383.6±131.8 | 15.4±10.8 | 6.6±2.2 |
| Distal M1 MCA ( | 2.9±0.6 | 2.2±0.5 | 141.2±37.1 | 41.2±8.2 | 124.2±32.6 | 357.4±131.8 | 14.5±9.5 | 6.5±2.0 |
| Proximal M2 MCA ( | 2.4±0.6 | 1.8±0.5 | 125.6±36.2 | 41.5±8.1 | 116.8±31.9 | 311.9±102.1 | 14.5±10.3 | 5.9±1.8 |
| Proximal A1 ACA ( | 2.4±0.6 | 1.7±0.5 | 133.4±43.9 | 42.9±8.4 | 112.5±30.4 | 318.7±106.2 | 15.8±11.8 | 5.8±2.1 |
| Distal A1 ACA ( | 2.3±0.5 | 1.7±0.4 | 124.5±47.2 | 43.0±8.8 | 106.6±26.0 | 296.4±97.9 | 13.1±7.7 | 6.2±2.1 |
| Proximal V4 VA ( | 3.2±1.2 | 2.3±0.9 | 152.0±50.9 | 38.4±9.9 | 160.2±83.0 | 431.3±212.9 | 17.8±13.1 | 6.1±2.5 |
| Distal V4 VA ( | 2.9±0.9 | 2.2±0.8 | 148.3±49.1 | 42.0±9.6 | 113.2±37.7 | 368.7±136.2 | 17.8±12.4 | 6.3±2.2 |
| Proximal BA ( | 3.7±1.0 | 2.9±0.8 | 165.5±51.9 | 43.7±11.0 | 117.0±32.7 | 407.0±175.8 | 14.7±12.3 | 7.8±2.9 |
| Distal BA ( | 3.4±0.9 | 2.6±0.6 | 165.5±52.6 | 45.9±9.1 | 109.0±32.7 | 377.9±145.6 | 13.8±10.7 | 7.6±2.7 |
| Proximal P1 PCA ( | 2.5±0.6 | 1.8±0.6 | 160.9±49.4 | 47.3±10.4 | 94.5±20.6 | 353.9±102.9 | 20.4±15.3 | 5.5±2.3 |
| Distal P1 PCA ( | 2.6±0.4 | 1.7±0.4 | 136.0±39.3 | 36.0±16.4 | 100.0±27.3 | 442.3±184.9 | 34.6±23.7 | 4.6±2.5 |
Abbreviations: mm, millimeters; um, micrometers; ICA, internal carotid artery; MCA, middle cerebral artery; ACA, anterior cerebral artery; BA, basilar artery; VA, vertebral artery; PCA, posterior cerebral artery; N, number.
ANOVA test resulted in P ≤ 0.001 for all comparisons.
Figure 2Relationship between arterial size and wall-to-lumen ratio. (A) Large arteries, largest to smallest. (B) Penetrating arteries, largest to smallest.
Penetrating arteries characteristics by parent artery segment.
| Proximal ICA (supraclinoid) ( | 365.9±265.0 | 238.6±205.6 | 19.3±16.3 | 29.9±10.5 | 37.7±22.7 | 59.9±12.1 | 13.7±5.5 | 3.7±1.7 |
| Distal ICA (supraclinoid) ( | 457.7±302.3 | 319.4±253.6 | 20.9±13.6 | 30.3±9.66 | 41.2±22.1 | 55.1±12.7 | 11.7±5.7 | 4.4±2.1 |
| Proximal M1 MCA ( | 386.3±254.4 | 264.5±201.7 | 18.4±13.4 | 29.8±9.03 | 35.8±22.2 | 55.7±12.5 | 12.4±5.9 | 4.4±2.3 |
| Distal M1 MCA ( | 431.7±281.5 | 299.5±229.2 | 21.4±14.7 | 31.7±9.40 | 37.2±18.9 | 55.5±11.6 | 12.1±4.7 | 4.3±2.0 |
| Proximal M2 MCA ( | 298.3±171.2 | 202.4±137.6 | 14.8±9.99 | 31.3±9.83 | 28.2±17.1 | 55.4±13.6 | 11.9±5.9 | 4.5±2.4 |
| Proximal A1 ACA ( | 323.1±204.0 | 213.5±158.5 | 16.8±11.2 | 31±9.22 | 32.3±19.9 | 58.4±11.1 | 13.1±5.3 | 3.9±2.1 |
| Distal A1 ACA ( | 301.7±174.3 | 205.1±130.2 | 15.9±11.0 | 33.5±9.82 | 27.1±18.3 | 54.4±13.2 | 12.3±6.7 | 4.6±2.3 |
| Proximal V4 VA ( | 452.6±158.8 | 321.6±132.2 | 21.4±9.95 | 31.6±8.61 | 35.0±10.6 | 50.3±10.8 | 11.4±5.9 | 5.1±1.9 |
| Distal V4 VA ( | 516.3±306.6 | 352±234.0 | 25.1±16.3 | 33.1±10.6 | 47.4±39.6 | 54.6±12.2 | 13.3±7.3 | 4.6±2.3 |
| Proximal BA ( | 455.8±206.9 | 309.6±172.9 | 23.4±12.7 | 32.3±10.4 | 41.0±20.8 | 55.3±12.8 | 13.3±7.1 | 4.4±2.0 |
| Distal BA ( | 537.9±282.2 | 387.4±248.2 | 26.6±12.7 | 36.2±10.6 | 39.7±22.9 | 50.9±12.7 | 11.4±5.5 | 5.2±2.6 |
| Proximal P1 PCA ( | 396.8±207.9 | 269±162.6 | 23.3±13.4 | 35.4±9.10 | 32.4±12.7 | 56.1±10.1 | 13.6±5.3 | 4.1±1.6 |
| Distal P1 PCA ( | 430.5±236.3 | 301.2±171.3 | 24.3±15.1 | 37±7.84 | 32.3±19.8 | 51.7±7.84 | 12.1±4.1 | 4.7±1.3 |
Abbreviations: mm, millimeters; um, micrometers; ICA, internal carotid artery; MCA, middle cerebral artery; ACA, anterior cerebral artery; BA, basilar artery; VA, vertebral artery; PCA, posterior cerebral artery; N, number.
ANOVA test resulted in P ≤ 0.001 for all comparisons except for stenosis where P > 0.05.
Beta coefficients for arterial size in association with arterial characteristics by clinical group.
Statistical significance:
P-value ≤ 0.05.
P-value > 0.05.
Abbreviations: AD, Alzheimer Dementia; SE, standard error; LA, large artery; SA, small artery; um, micrometers.
Cardiovascular profile of the studied sample compared to the US and NY populations.
| Age (years) | ||||||
| Mean ± SD (SE for NNAHES and NYC HANES) | 55.4 ± 17 | 47.3 ± 0.1 | 46.0 ± 0.7 | 46.7 ± 6.8 | 44.0 ± 0.6 | na |
| Median | 51 | 46 | 43 | 47 | 42 | na |
| Range | 81 | 59 | 68 | 30 | 35 | na |
| Male sex (%) | 73 | 50 (48–51) | 46 (43–48) | 75 | 74 (57–92) | 57 |
| Ethnicity (%) | ||||||
| NH whites | 74 | 66 (58–74) | 38 (36–41) | 17 | 22 (1–50) | 10 |
| Hispanics | 14 | 16 (9–23) | 26 (24–28) | 33 | 23.2 (15–31) | 30 |
| Black | 12 | 11 (9–13) | 23 (20–24) | 50 | 55 (28–82) | 55 |
| Hypertension (%) | 38 | 30 (27–33) | 26 (23–28) | 59 | 26 (8–44) | na |
| Diabetes (%) | 15 | 9.0 (8–10) | 8 (7–10) | 16 | 17 (1–43) | na |
| Dyslipidemia (%) | 19 | 41 (38–53) | 31 (28–33) | 21 | 38 (1–82) | na |
| Smoking (%) | 48.5 | 20 (18–22) | 24 (21–26) | 52 | 36 (2–52) | na |
| Cocaine use (%) | 6 | 3 (2–4) | 3 (2–4) | 41 | 20 (5–37) | na |
| ARV use | Not applicable | 53 | 53 (25–80) | na | ||
NHANES limited testing HIV serology to age range 20–59 years old.
For autopsy population, ARV use determined at the time of death.
Ref: Nguyen et al. AIDS. 2008 Jan 11; 22(2):281–287, unweighted estimates.
Risk factors definition: Hypertension (htn), diabetes (dm) and dyslipidemia in NHANES and NYC-HANES were limited to self-report of a physician diagnosis of htn or use of antihypertensives, self-report of a physician diagnosis of dm or use of hypoglycemic medications including insulin, and self-report of a physician diagnosis of dyslipidemia or use of hypolipemic drugs. Smoking was defined as individuals who reported smoking more than 100 cigarettes in their life time and who currently smoke either some or all days. Cocaine use was defined as present if it occurred over the year prior to the interview. HIV status in NHANES was determined by a positive ELISA HIV test in blood. The HIV results from NYC-HANES are not publicly available. For the NHANES and NYC-HANES prevalence of vascular risks factors, the estimates were weighted to account for oversampling and non-response. We used survey procedures to obtain the means and their standard errors. The analysis was carried out with SAS software, version 9.3 (SAS Institute Inc., Cary, NC).
Abbreviations: ARV, antiretroviral therapy; na, not applicable; NYC, New York City; NHANES, National Health and Nutrition Examination Survey.